...
机译:HBV HBV与HCV HCV的循环TFH细胞分布和损害HCV HCV中和抗体反应
Translational Medicine InstituteUniversity of South ChinaChenzhou Hunan China;
Translational Medicine InstituteUniversity of South ChinaChenzhou Hunan China;
Translational Medicine InstituteUniversity of South ChinaChenzhou Hunan China;
Translational Medicine InstituteUniversity of South ChinaChenzhou Hunan China;
Translational Medicine InstituteUniversity of South ChinaChenzhou Hunan China;
Translational Medicine InstituteUniversity of South ChinaChenzhou Hunan China;
Translational Medicine InstituteUniversity of South ChinaChenzhou Hunan China;
Translational Medicine InstituteUniversity of South ChinaChenzhou Hunan China;
Translational Medicine InstituteUniversity of South ChinaChenzhou Hunan China;
Translational Medicine InstituteUniversity of South ChinaChenzhou Hunan China;
Translational Medicine InstituteUniversity of South ChinaChenzhou Hunan China;
Translational Medicine InstituteUniversity of South ChinaChenzhou Hunan China;
coinfection; hepatitis B virus; hepatitis C virus; neutralizing antibody response; T follicular helper cell;
机译:HBV HBV与HCV HCV的循环TFH细胞分布和损害HCV HCV中和抗体反应
机译:HCV感染和HBV-HCV合并感染患者全血中丙型肝炎病毒RNA的分布。
机译:循环CXCR3 + TFH细胞与HCV感染患者中的中和抗体应答呈正相关
机译:Peginterferon Alfa-2a(Pegasys)的安全性为180 mcg每周加上利韦韦林(RBV)800mg在HIV / HCV辛纤维中每日800毫克,与HCV单键相比
机译:HCV包膜假型病毒颗粒的开发,用于评估HCV包膜加工中涉及的HCV进入抑制剂和细胞蛋白酶。
机译:慢性乙型肝炎病毒(HBV)携带者中的急性丙型肝炎病毒(HCV)感染:潜在的活跃HBV复制对HCV感染持续性和对HCV的抗体反应的影响
机译:慢性乙型肝炎病毒(HBV)携带者中的急性丙型肝炎病毒(HCV)感染:潜在的活跃HBV复制对HCV感染持续性和对HCV的抗体反应的影响